Amy Abernethy

Amy Abernethy is a leader in real-world evidence generation who served as Principal Deputy Commissioner at the FDA where she championed RWD-driven regulatory decision-making. Her work at Flatiron Health pioneered the use of EHR-derived endpoints for oncology research, enabling regulatory-grade real-world evidence at scale. She continues to advance the integration of real-world data into clinical development and post-market surveillance.